MX2008009493A - Peptido novedoso y uso del mismo. - Google Patents

Peptido novedoso y uso del mismo.

Info

Publication number
MX2008009493A
MX2008009493A MX2008009493A MX2008009493A MX2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A
Authority
MX
Mexico
Prior art keywords
amino acid
acid sequence
peptide
novel peptide
seq
Prior art date
Application number
MX2008009493A
Other languages
English (en)
Inventor
Sung-Hoon Kim
Jung-Min Han
Original Assignee
Imagene Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imagene Co Ltd filed Critical Imagene Co Ltd
Publication of MX2008009493A publication Critical patent/MX2008009493A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factors [FGF]

Abstract

La presente invención se relaciona con un péptido novedoso y uso del mismo, más en particular a un péptido aislado que comprende 21-41 aminoácidos contiguos seleccionados de la secuencia de aminoácido de SEQ ID NO:1 o la secuencia de aminoácido que tiene al menos una homología de secuencia de 90% con la secuencia de aminoácido de SE! ID NO: 1 y métodos para promover la proliferación de fibroblastos y curación de heridas, que comprende administrar a un sujeto que lo necesite una cantidad efectiva de) péptido.
MX2008009493A 2006-01-23 2006-01-23 Peptido novedoso y uso del mismo. MX2008009493A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2006/000252 WO2007083853A1 (en) 2006-01-23 2006-01-23 Novel peptide and use thereof

Publications (1)

Publication Number Publication Date
MX2008009493A true MX2008009493A (es) 2008-10-03

Family

ID=38287791

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008009493A MX2008009493A (es) 2006-01-23 2006-01-23 Peptido novedoso y uso del mismo.

Country Status (9)

Country Link
US (1) US20090305973A1 (es)
EP (1) EP1976864B1 (es)
JP (1) JP5002603B2 (es)
KR (1) KR101020658B1 (es)
CN (1) CN101370821B (es)
AU (1) AU2006335748A1 (es)
CA (1) CA2640064A1 (es)
MX (1) MX2008009493A (es)
WO (1) WO2007083853A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101111222A (zh) * 2005-02-01 2008-01-23 伊玛吉恩有限公司 刺激胶原蛋白合成和/或kgf表达的方法
US8022037B2 (en) 2007-01-08 2011-09-20 University Of Southern California Skin wound healing compositions and methods of use thereof
AU2008211884A1 (en) * 2007-02-01 2008-08-07 Imagene Co., Ltd. Novel polypeptide having anti-tumor activity
CN101824083B (zh) * 2009-03-06 2014-01-15 信谊药厂 C端缺失型p43蛋白及其在肿瘤治疗药物中的应用
ES2742251T3 (es) 2009-03-16 2020-02-13 Pangu Biopharma Ltd Composiciones y procedimientos que comprenden variantes de splicing de histidil-tarn sintetasa que tienen actividades biológicas no canónicas
US8207118B2 (en) * 2009-07-17 2012-06-26 University Of Southern California Skin wound healing compositions and methods of use thereof
EP2939689B1 (en) 2009-12-11 2017-09-13 aTyr Pharma, Inc. Glutaminyl tRNA synthetases for use in the treatment of inflammatory disorders
US20130202576A1 (en) 2010-07-12 2013-08-08 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
CN103458914B (zh) * 2010-11-03 2015-11-25 南加利福尼亚大学 皮肤伤口愈合组合物及其使用方法
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
US9688978B2 (en) 2011-12-29 2017-06-27 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
EP3311847A1 (en) 2012-02-16 2018-04-25 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
EP3460054B1 (en) 2013-03-15 2020-10-21 aTyr Pharma, Inc. Histidyl-trna synthetase-fc conjugates
US10188694B2 (en) 2016-03-23 2019-01-29 Bio Pep Co., Ltd. Peptide for skin regeneration or wound treatment and use thereof
US10995117B2 (en) 2016-03-23 2021-05-04 Kine Sciences Co., Ltd. Peptide for skin regeneration or wound treatment and use thereof
KR101996490B1 (ko) * 2016-05-31 2019-07-03 인하대학교 산학협력단 간질환 예방 또는 치료용 펩타이드 및 이를 유효성분으로 포함하는 조성물
KR102017796B1 (ko) * 2016-07-28 2019-09-03 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
KR102336341B1 (ko) * 2016-07-28 2021-12-08 주식회사 네오믹스 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 피부 보호용 조성물
WO2018195338A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
KR102346050B1 (ko) * 2019-01-25 2022-01-03 주식회사 네오믹스 미백 활성을 갖는 신규 폴리펩타이드 및 이의 용도
KR102024055B1 (ko) * 2019-08-14 2019-09-24 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US5556645A (en) * 1990-01-12 1996-09-17 Bockman; Richard Methods of enhancing wound healing and tissue repair
US5886141A (en) * 1990-10-26 1999-03-23 Takeda Chemical Industries, Ltd. Smooth muscle mitogen peptides and DNA coding therefor
US5981606A (en) 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5149691A (en) 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
US6800286B1 (en) * 1998-08-19 2004-10-05 The Regents Of The University Of Colorado Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof
JP2002542145A (ja) * 1998-11-13 2002-12-10 チルドレンズ・ホスピタル・オヴ・ロス・アンジェルス 血管成長を促進する方法
US6616648B2 (en) * 2000-03-31 2003-09-09 Sca Hygiene Products Ab Absorbent article having v-shaped elastic attached to backsheet
KR100405919B1 (ko) * 2001-06-05 2003-11-14 주식회사 이매진 ｐ43의 Ｎ-말단 펩타이드를 유효성분으로 하는 면역증강용 약학조성물
KR100515016B1 (ko) * 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 ｐ43을 유효성분으로 하는 창상 치료용 약학적 조성물
CN101111222A (zh) * 2005-02-01 2008-01-23 伊玛吉恩有限公司 刺激胶原蛋白合成和/或kgf表达的方法
AU2008211884A1 (en) * 2007-02-01 2008-08-07 Imagene Co., Ltd. Novel polypeptide having anti-tumor activity

Also Published As

Publication number Publication date
CN101370821A (zh) 2009-02-18
KR101020658B1 (ko) 2011-03-09
CA2640064A1 (en) 2007-07-26
EP1976864A1 (en) 2008-10-08
US20090305973A1 (en) 2009-12-10
JP2009523844A (ja) 2009-06-25
CN101370821B (zh) 2012-07-18
JP5002603B2 (ja) 2012-08-15
WO2007083853A1 (en) 2007-07-26
EP1976864B1 (en) 2012-09-26
AU2006335748A1 (en) 2007-07-26
EP1976864A4 (en) 2010-09-01
KR20080103511A (ko) 2008-11-27

Similar Documents

Publication Publication Date Title
MX2008009493A (es) Peptido novedoso y uso del mismo.
NZ600690A (en) Fkbp-l and uses thereof
IN2014CN02050A (es)
NZ601868A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
MX348464B (es) Agente inductor de inmunidad.
NZ595063A (en) Polypeptides from neisseria meningitidis
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
NZ597306A (en) Mesenchymal stem cell differentiation
NZ607892A (en) Tfpi inhibitors and methods of use
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
EP2039367A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASES
NZ703514A (en) Fviii peptides for immune tolerance induction and immunodiagnostics
NZ590469A (en) Treatment of rheumatoid arthritis with human beta defensins (1-4)
WO2010057242A3 (de) Vakzin
HK1121383A1 (en) Wound healing agent and composition
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
EP3026057A3 (en) Compositions for prevention and treatment of neurodegenerative diseases
EP1765851A4 (en) OPTICAL CHEMO AND BIOSENSORS BASED ON A PLANAR RESONATOR
ATE552271T1 (de) Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
GB201018125D0 (en) Peptide
HK1131162A1 (en) Cytokine derivatives

Legal Events

Date Code Title Description
FG Grant or registration